Contract win

AI SummaryClose X

Fusion Antibodies PLC has been selected for a new multi-target Integrated Therapeutic Antibody Services project with a global pharmaceutical company's Antibody Centre of Excellence. The project, under a Master Service Agreement, will focus on humanisation and supply elements, specifically humanising a family of VHH antibody fragments. Fusion will also handle the expression, purification, and supply of research materials. Work on this project is expected to be completed within the current financial year, with the company anticipating revenues of not less than £175,000. This contract aligns with Fusion's strategy to secure contracts with major pharmaceutical businesses and exploit its technologies for sustainable growth.

Disclaimer*

UK 100

Latest directors dealings